Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > PP

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Nov 17, 2022 8:23pm

209 Views

Post# 35109037

RE:RE:RE:RE:RE:RE:PP

Out of the 1,000,000 shares, Roger bought 411,000 shares @0.25$.

We should soon see how the remaining 589,000 shares were split.

Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	Volume or Value	Price
Nov 17/22	Nov 17/22	Dumoulin-White, Roger John	Direct Ownership	Warrants	16 - Acquisition under a prospectus exemption	411,000	$0.350
Nov 17/22	Nov 17/22	Dumoulin-White, Roger John	Direct Ownership	Common Shares	16 - Acquisition under a prospectus exemption	411,000	$0.250